CD160-competent ILC2 are crucial for the ejection of intestinal helminths by the innate immune system
ILC2 progressively lost CD160 expression and acquired cytokine-producing capacity. While CD160-competent RAG KO mice efficiently controlled S. ratti infection with less than 1% of the infective dose remaining by day 10 post-infection, CD160-deficient RAG KO mice failed to expand intestinal ILC2, failed to activate mucosal mast cells and retained high intestinal worm burden for nearly 100 days. Adoptive transfer of CD160-competent ILC2 into S. ratti-infected CD160-deficient RAG KO mice partially restored mast cell activation and reduced intestinal worm burden by 50%. Collectively, these findings identify CD160 expression as a critical checkpoint in the development and expansion of fully functional ILC2 required for effective immunity against intestinal helminth infection.
Authors
- Henry J. McSorley (ORCID: https://orcid.org/0000-0003-1300-7407)
- Lennart Heepmann
- Zane Orinska (ORCID: https://orcid.org/0000-0003-0834-5321)
- Wiebke Hartmann (ORCID: https://orcid.org/0000-0002-4998-0586)
- Minka Breloer (ORCID: https://orcid.org/0000-0001-6199-4908)
- Lara Linnemann (ORCID: https://orcid.org/0000-0003-4963-2888)
- Thomas Jacobs (ORCID: https://orcid.org/0000-0003-3313-7866)
- Birte Viebrock
- Sara Dörken
Institutions
- Universität Hamburg (DE)
- University of Dundee (GB)
- German Center for Lung Research (DE)
- Bernhard Nocht Institute for Tropical Medicine (DE)
Publication Details
- Journal
- Mucosal Immunology
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1016/j.mucimm.2026.04.005
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Joachim Herz Stiftung
- Deutsche Forschungsgemeinschaft